Research Article
Normal and Reversed-Phase HPTLC Methods for Simultaneous Estimation of Telmisartan and Metoprolol Succinate in Pharmaceutical Formulation
| | Method | Drugs | Initial amount (ng per band) | Amount added (%) | % recovery | % RSD () |
| | Method I | TELMI | 1400 | 80 | 99.39 | 0.65 | | 1400 | 100 | 99.59 | 0.38 | | 1400 | 120 | 99.66 | 0.28 | | MET | 1750 | 80 | 99.27 | 0.66 | | 1750 | 100 | 99.01 | 0.46 | | 1750 | 120 | 99.00 | 0.52 |
| | Method II | TELMI | 1400 | 80 | 98.83 | 1.09 | | 1400 | 100 | 99.79 | 0.78 | | 1400 | 120 | 99.57 | 0.39 | | MET | 1750 | 80 | 98.27 | 1.08 | | 1750 | 100 | 99.00 | 0.61 | | 1750 | 120 | 99.00 | 0.65 |
|
|
